Duopharma Biotech Bhd (XKLS:7148) Pre-Tax Income

Duopharma Biotech Bhd Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Pre-Tax Income							59.67	70.81	76.16	82.98	84.85

Duopharma Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Pre-Tax Income																21.39	15.35	28.29	16.52	11.43

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Pre-Tax Income falls into.

Duopharma Biotech Bhd Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Duopharma Biotech Bhd's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Duopharma Biotech Bhd's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM71.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Duopharma Biotech Bhd  (XKLS:7148) Pre-Tax Income Explanation

Duopharma Biotech Bhd's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

During the past 13 years, Duopharma Biotech Bhd's highest Pretax Margin was 26.28%. The lowest was 10.06%. And the median was 12.63%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Duopharma Biotech Bhd Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd (XKLS:7148) Business Description